A review of the use of magnetic resonance imaging in Parkinson's disease

N Pyatigorskaya, C Gallea… - Therapeutic …, 2014 - journals.sagepub.com
To date, the most frequently used Parkinson’s disease (PD) biomarkers are the brain imaging
measures of dopaminergic dysfunction using positron emission tomography and single …

The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder

M Ehrminger, A Latimier, N Pyatigorskaya… - Brain, 2016 - academic.oup.com
See Boeve et al . (doi: 10.1093/brain/aww030 ) for a scientific commentary on this article.
Idiopathic rapid eye movement sleep behaviour disorder is characterized by nocturnal violence…

Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease

…, L Yahia-Cherif, G Mangone, N Pyatigorskaya… - Brain, 2020 - academic.oup.com
This study aimed to investigate the spatiotemporal changes in neuromelanin-sensitive MRI
signal in the substantia nigra and their relation to clinical scores of disease severity in …

Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder

N Pyatigorskaya, R Gaurav, D Arnaldi… - Sleep, 2017 - academic.oup.com
Objectives Idiopathic rapid eye movement sleep behavior disorder (iRBD) is considered to
be a prodromal stage of Parkinson’s disease (PD). At PD onset, 40 to 70% of the …

Automated categorization of parkinsonian syndromes using magnetic resonance imaging in a clinical setting

L Chougar, J Faouzi, N Pyatigorskaya… - Movement …, 2021 - Wiley Online Library
Nadya Pyatigorskaya designed and conceptualized the study and revised the manuscript
for intellectual content. Lydia Yahia-Cherif performed data analysis and revised the manuscript…

Brain MRI findings in severe COVID-19: a retrospective observational study

…, G Boulouis, J Berge, A Kazémi, N Pyatigorskaya… - Radiology, 2020 - pubs.rsna.org
Background Brain MRI parenchymal signal abnormalities have been associated with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose To describe the …

Longitudinal changes in neuromelanin MRI signal in Parkinson's disease: a progression marker

R Gaurav, L Yahia‐Cherif, N Pyatigorskaya… - Movement …, 2021 - Wiley Online Library
Background Development of reliable and accurate imaging biomarkers of dopaminergic cell
neurodegeneration is necessary to facilitate therapeutic drug trials in Parkinson's disease (…

Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study

…, G Boulouis, J Berge, A Kazémi, N Pyatigorskaya… - Neurology, 2020 - AAN Enterprises
Objective To describe neuroimaging findings and to report the epidemiologic and clinical
characteristics of patients with coronavirus disease 2019 (COVID-19) with neurologic …

Parkinson disease propagation using MRI biomarkers and partial least squares path modeling

N Pyatigorskaya, L Yahia-Cherif, R Valabregue… - Neurology, 2021 - AAN Enterprises
Objectives The classic Braak neuropathologic staging model in Parkinson disease (PD)
suggests that brain lesions progress from the medulla oblongata to the cortex. An alternative …

Multimodal magnetic resonance imaging quantification of brain changes in progressive supranuclear palsy

N Pyatigorskaya, L Yahia‐Cherif, R Gaurav… - Movement …, 2020 - Wiley Online Library
Background Progressive supranuclear palsy (PSP) is a neurodegenerative clinically
heterogeneous disorder, formal diagnosis being based on postmortem histological brain …